What is SYPR's health score?

SYPRIS SOLUTIONS INC (SYPR) has a TradeApes health score of 59 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is SYPR's estimated fair value?

Based on our 5-year discounted cash flow model, SYPRIS SOLUTIONS INC's estimated fair value is $0.25 per share, representing a -92.1% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is SYPR undervalued or overvalued?

Our model currently rates SYPR as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for SYPR... Refresh in a moment for the full analysis.

SYPRIS SOLUTIONS INC (SYPR)

Healthcare Overvalued low mixed

$3.18

Updated: 2026-06-05

TradeApes Score

Financial Strength

55 Mixed

Operating Trend

50 Mixed

Relative Value

70 Healthy

Capital Allocation

55 Mixed

Risk

70 Healthy

Est. Fair Value $0.25

DCF Upside -92.1%

Sector Rank #1814 of 6432

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− Thin interest coverage — EBIT covers interest just 2–4×

Unlock Full Report →

2 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.